Aurigene Oncology reports positive outcomes of Phase 1 trial for CAR-T cell therapy in India
- Posted on October 8, 2024
- By Financial Express
- 1 Views
Aurigene Oncology reports positive outcomes of Phase 1 trial for CAR-T cell therapy in India
According to the company's press statement, it is India’s first trial for a novel autologous BCMA directed CAR-T cell therapy in patients with relapsed / refractory multiple myeloma.
